ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach-Reference-Cited by-同舟云学术

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

Published:2019-08 Issue:8 Volume:30 Page:1232-1243
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Luchini C.^ORCID,Bibeau F.,Ligtenberg M.J.L.,Singh N.,Nottegar A.,Bosse T.,Miller R.,Riaz N.,Douillard J.-Y.,Andre F.,Scarpa A.

Funder

European Society for Medical Oncology

Roche

AstraZeneca Schweiz

Pfizer

Merck

British Microcirculation Society

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz116/28556523/mdz116.pdf

Reference105 articles.

1. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer;Lawes;Eur J Surg Oncol,2003

2. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1;Ligtenberg;Nat Genet,2009

3. Cancer predisposition syndromes: lessons for truly precision medicine;Glaire;J Pathol,2017

4. Microsatellite instability as a biomarker for PD-1 blockade;Dudley;Clin Cancer Res,2016

5. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors;Hargadon;Int Immunopharmacol,2018

Cited by 692 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies for the treatment of colorectal cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies;Annals of Hepatology;2024-11

3. Performance of the Idylla microsatellite instability test in endometrial cancer;Molecular and Cellular Probes;2024-10

4. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

5. Prophylaxis with abemaciclib delays tumorigenesis in dMMR mice by altering immune responses and reducing immunosuppressive extracellular vesicle secretion;Translational Oncology;2024-09